Satellite Symposia & Meet the Expert Sessions

12:30 – 13:30                

Congress Hall K

The familial mediterranean fever case kaleidoscope: Strategies to optimize diagnosis and long-term management

Organized by Medscape Global Education | Supported by independent funding from Novartis

Meet Julia: Introduction to the patient journey
Marco Gattorno (IT)

The diagnostic dilemma: Where clinical judgment meets genetic insight
Marco Gattorno (IT) & Ahmet Gül (TR)

The journey continues: Tailoring FMF management with biologics
Marco Gattorno (IT) & Ruby Haviv (IL)

Optimizing long-term management with biologics: Weighing the risks of
subclinical inflammation and long-term complications
All

The FMF case kaleidoscope: An interactive panel discussion with audience
All

16:00 – 17:00

Congress Hall K

Exploring the future of macrophage activation syndrome in Still’s disease

Organized by Sobi

16:00 - 16:02

Introduction
Fabrizio De Benedetti (IT)

16:02 - 16:17

Day to day challenges in patient management
Fatma Dedeoglu (US)

16:17 - 16:32

Unravelling the mechanisms
Petter Brodin (SE)

16:32 - 16:47

Emerging management strategies
Fabrizio De Benedetti (IT)

16:47 - 17:00

Q&A
All

12:30 – 13:30     

Congress Hall K

Navigating the complex world of recurrent fevers – Perspectives from the bench and bedside

Organized by Sobi

12:30 - 12:35

Chair’s welcome
Jasmin Kümmerle-Deschner (DE)

12:35 - 12:45

Inflammasome-mediated autoinflammatory diseases
Lori Broderick (US)

12:45 - 12:55

Familiar and less familiar faces of FMF
Yosef Uziel (IL)

12:55 - 13:05

Tackling FMF with a patient-oriented approach
Jasmin Kümmerle-Deschner (DE)

13:05 - 13:15

Is it FMF? Is it PFAPA? Could it be SURF?
Marco Gattorno (IT)

13:15 - 13:20

Q&A
All

13:20 - 13:30

Chair’s closing remarks
Jasmin Kümmerle-Deschner (DE)

16:00 – 17:00    

Congress Hall K

Bringing forward IL-6 Inhibition in the era of biosimilars

Organized by Fresenius Kabi

16:00 - 16:05

Opening
Gerd Horneff (DE)

16:05 - 16:20

Why choosing biosimilars in pediatric rheumatology?
Gerd Horneff (DE)

16:20 - 16:35

Role of IL-6 Inhibition in pJIA and sJIA
Fabrizio De Benedetti (IT)

16:35 - 16:55

Selected clinical cases (including voting system
for interactive discussion)
Marco Gattorno (IT)

16:55 - 17:00

Closing
Gerd Horneff (DE)

16:30 – 17:00

H1+H2

Meet the Expert: Recent data on Baricitinib and Ixekizumab in JIA

Organized by Eli Lilly

Speaker: Athimalaipet Ramanan (UK)